Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MIRZA W AHMED

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1376653634
CMS profile
198951
Location
LONDON, KY

General Payments · PY2018–2024

$25,232.93

  • Reported across 103 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$427.39

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $427.39 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $118.94 1
Amgen Inc. $92.44 3
Novo Nordisk AS $64.00 3
BOSTON SCIENTIFIC CORPORATION $56.95 2
E.R. Squibb & Sons, L.L.C. $26.00 1
Merck Sharp & Dohme Corporation $23.17 1
PFIZER INC. $23.14 1
Exact Sciences Corporation $22.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,747.66 16
PY2019 $5,092.19 15
PY2020 $4,885.06 6
PY2021 $8,221.37 10
PY2022 $270.65 12
PY2023 $588.61 31
PY2024 $427.39 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $44.86 01/21/2024 Food and Beverage Undisputed 01/23/2026 1115412004 CMS
Amgen Inc. $22.97 02/20/2024 Food and Beverage Undisputed 01/23/2026 1115412000 CMS
Amgen Inc. $24.61 08/06/2024 Food and Beverage Undisputed 01/23/2026 1115412008 CMS
Boston Scientific Corporation $25.10 02/23/2024 Food and Beverage Undisputed 01/23/2026 1092485915 CMS
Boston Scientific Corporation $31.85 05/22/2024 Food and Beverage Undisputed 01/23/2026 1092485917 CMS
E.R. Squibb & Sons, L.L.C. $26.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 1101813240 CMS
Exact Sciences Corporation $22.75 05/24/2024 Food and Beverage Undisputed 01/23/2026 1114571384 CMS
Lilly USA, LLC $118.94 07/16/2024 Food and Beverage Undisputed 01/23/2026 1135210296 CMS
Merck Sharp & Dohme LLC $23.17 01/31/2024 Food and Beverage Undisputed 01/23/2026 1141951439 CMS
Novo Nordisk Inc $21.22 01/30/2024 Food and Beverage Undisputed 01/23/2026 1097331677 CMS
Novo Nordisk Inc $22.10 05/20/2024 Food and Beverage Undisputed 01/23/2026 1097231097 CMS
Novo Nordisk Inc $20.68 10/22/2024 Food and Beverage Undisputed 01/23/2026 1096601769 CMS
PFIZER INC. $23.14 08/09/2024 Food and Beverage Undisputed 01/23/2026 1131866850 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.